Scarica l'app Stockscreener
3.33
1.19%
-0.04
Dopo l'orario di chiusura:
3.33
Precedente Chiudi:
$3.37
Aprire:
$3.2
Volume 24 ore:
705.75K
Relative Volume:
0.62
Capitalizzazione di mercato:
$421.78M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-37.00
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
+0.91%
1M Prestazione:
+3.10%
6M Prestazione:
-41.99%
1 anno Prestazione:
-46.97%
Intervallo 1D:
$3.20
$3.39
Intervallo di 1 settimana:
$3.09
$3.425
Portata 52W:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.33 | 411.64M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
10 Promising SmallCap Stocks Under $1 Billion Market Cap - Insider Monkey
Cytek Biosciences, Inc. (CTKB): A Bull Case Theory - Insider Monkey
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewswire
Cytek Biosciences Inc. Stock Analysis and ForecastExceptional gains - Autocar Professional
Cytek Biosciences to Release Second Quarter 2025 Financial Results on August 6, 2025 - Nasdaq
What analysts say about Cytek Biosciences Inc. stockMassive profits - Autocar Professional
What drives Cytek Biosciences Inc. stock priceFree Stock Market Return Analysis - jammulinksnews.com
Where are the Opportunities in (CTKB) - news.stocktradersdaily.com
Is Cytek Biosciences Inc. a good long term investmentFree Stock Market Beginners Guide - jammulinksnews.com
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Acquired by Principal Financial Group Inc. - Defense World
Should I buy Cytek Biosciences Inc. stock before earningsLow Risk Profit Ideas - Newser
Teacher Retirement System of Texas Decreases Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
How Cytek Biosciences Inc. stock performs during market volatilityDaily Swing Candidates - Newser
What makes Cytek Biosciences Inc. stock price move sharplyFree Expert-Led Investment Training - Newser
Why Cytek Biosciences Inc. stock attracts strong analyst attentionFree Financial Group - Newser
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by New York State Teachers Retirement System - Defense World
Wealth Enhancement Advisory Services LLC Invests $63,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
MDxHealth names Michael Holder to board, CFO Ron Kalfus to depart - Investing.com
Research device company to relocate local office to Bellevue - The Business Journals
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.4% – Still a Buy? - Defense World
3 Promising Penny Stocks With Market Caps At Least $300M - Yahoo Finance
Cytek Biosciences Elects New Directors at Annual Meeting - TipRanks
Ratios Revealed: Decoding Cytek BioSciences Inc (CTKB)’s Financial Health - DWinneX
Flow Cytometer | Cytek Biosciences Inc. | Products - Photonics Spectra
Cytek Biosciences at Goldman Sachs Conference: Growth Amidst Challenges By Investing.com - Investing.com Canada
Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Cytek Biosciences (CTKB) Faced Challenges from NIH Funding Reductions - Insider Monkey
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 22,433 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences Plunges 10.18% Amid Product Discontinuation Concerns - AInvest
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
Insider Buying: William Mccombe Acquires 35,000 Shares of Cytek Biosciences Inc (CTKB) - GuruFocus
Bank of America Corp DE Boosts Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences Leads Our Top 3 Penny Stock Selections - Yahoo Finance
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):